1. Home
  2. GRI vs MRIN Comparison

GRI vs MRIN Comparison

Compare GRI & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRI
  • MRIN
  • Stock Information
  • Founded
  • GRI 2018
  • MRIN 2006
  • Country
  • GRI United States
  • MRIN United States
  • Employees
  • GRI N/A
  • MRIN N/A
  • Industry
  • GRI Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • GRI Health Care
  • MRIN Technology
  • Exchange
  • GRI Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • GRI 3.2M
  • MRIN 2.7M
  • IPO Year
  • GRI N/A
  • MRIN 2013
  • Fundamental
  • Price
  • GRI $1.35
  • MRIN $0.90
  • Analyst Decision
  • GRI Strong Buy
  • MRIN
  • Analyst Count
  • GRI 2
  • MRIN 0
  • Target Price
  • GRI $22.00
  • MRIN N/A
  • AVG Volume (30 Days)
  • GRI 110.6K
  • MRIN 6.4M
  • Earning Date
  • GRI 08-13-2025
  • MRIN 07-31-2025
  • Dividend Yield
  • GRI N/A
  • MRIN N/A
  • EPS Growth
  • GRI N/A
  • MRIN N/A
  • EPS
  • GRI N/A
  • MRIN N/A
  • Revenue
  • GRI N/A
  • MRIN $16,707,999.00
  • Revenue This Year
  • GRI N/A
  • MRIN N/A
  • Revenue Next Year
  • GRI N/A
  • MRIN N/A
  • P/E Ratio
  • GRI N/A
  • MRIN N/A
  • Revenue Growth
  • GRI N/A
  • MRIN N/A
  • 52 Week Low
  • GRI $1.10
  • MRIN $0.41
  • 52 Week High
  • GRI $43.69
  • MRIN $3.39
  • Technical
  • Relative Strength Index (RSI)
  • GRI 41.49
  • MRIN 47.69
  • Support Level
  • GRI $1.20
  • MRIN $0.86
  • Resistance Level
  • GRI $1.35
  • MRIN $1.10
  • Average True Range (ATR)
  • GRI 0.10
  • MRIN 0.22
  • MACD
  • GRI 0.02
  • MRIN -0.02
  • Stochastic Oscillator
  • GRI 37.60
  • MRIN 6.52

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: